|
1
|
Bialešová L, Brtko J, Lenko V and Macejová
D: Nuclear receptors-target molecules for isoflavones in cancer
chemoprevention. Gen Physiol Biophys. 32:467–478. 2013. View Article : Google Scholar
|
|
2
|
Brtko J: Role of retinoids and their
cognate nuclear receptors in breast cancer chemoprevention. Cent
Eur J Public Health. 15:3–6. 2007.PubMed/NCBI
|
|
3
|
Hua F, Fang N, Li X, Zhu S, Zhang W and Gu
J: A meta-analysis of the relationship between RARβ gene promoter
methylation and non-small cell lung cancer. PloS One. 9:e961632014.
View Article : Google Scholar
|
|
4
|
Liu Z, Zhang L, Ding F, Li J, Guo M, Li W,
Wang Y, Yu Z, Zhan Q, Wu M and Liu Z: 5-Aza-2′-deoxycytidine
induces retinoic acid receptor-beta(2) demethylation and growth
inhibition in esophageal squamous carcinoma cells. Cancer Lett.
230:271–283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pérez RJ, Benoit YD and Gudas LJ: Deletion
of retinoic acid receptor β (RARβ) impairs pancreatic endocrine
differentiation. Exp Cell Res. 319:2196–2204. 2013. View Article : Google Scholar
|
|
6
|
Terra AP, Murta EF, Maluf PJ, Caballero
OL, Brait M and Adad SJ: Aberrant promoter methylation can be
useful as a marker of recurrent disease in patients with cervical
intraepithelial neoplasia grade III. Tumori. 93:572–579. 2007.
|
|
7
|
Moison C, Assemat F, Daunay A, Tost J,
Guieysse-Peugeot AL and Arimondo PB: Synergistic chromatin
repression of the tumor suppressor gene RARB in human prostate
cancers. Epigenetics. 9:477–482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alvarez S, Germain P, Alvarez R,
Rodríguez-Barrios F, Gronemeyer H and de Lera AR: Structure,
function and modulation of retinoic acid receptor beta, a tumor
suppressor. Int J Biochem Cell Biol. 39:1406–1415. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng X, Green A, Shilkaitis A, Zhu Y,
Bratescu L and Christov K: Early in vitro passages of breast cancer
cells are differentially susceptible to retinoids and
differentially express RARβ isoforms. Int J Oncol. 39:577–583.
2011.PubMed/NCBI
|
|
10
|
Fernández-Martínez AB and Lucio Cazaña FJ:
Epidermal growth factor receptor transactivation by intracellular
prostaglandin E2-activated prostaglandin E2 receptors. Role in
retinoic acid receptor-β up-regulation. Biochim Biophys Acta.
1833:2029–2038. 2013. View Article : Google Scholar
|
|
11
|
Bu P and Wan YJ: Fenretinide-induced
apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid
receptor beta dependent. BMC Cancer. 7:2362007. View Article : Google Scholar
|
|
12
|
Zhang W and Yan LN: Perihilar
cholangiocarcinoma: Current therapy. World J Gastrointest
Pathophysiol. 5:344–354. 2014.PubMed/NCBI
|
|
13
|
Unno M: Review of surgical treatment of
perihilar cholangiocarcinoma: Proper patient selection for combined
vascular resection and reconstruction. Nihon Geka Gakkai zasshi.
115:181–184. 2014.In Japanese. PubMed/NCBI
|
|
14
|
Demonceau J, Ruppar T, Kristanto P, Hughes
DA, Fargher E, Kardas P, De Geest S, Dobbels F, Lewek P, Urquhart
J, et al: Identification and assessment of adherence-enhancing
interventions in studies assessing medication adherence through
electronically compiled drug dosing histories: A systematic
literature review and meta-analysis. Drugs. 73:545–562. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang GL, Luo Q, Rui G, Zhang W, Zhang QY,
Chen QX and Shen DY: Oncogenic activity of retinoic acid receptor γ
is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin
pathways in cholangiocarcinoma. Mol Cell Biol. 33:3416–3425. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen DY, Fang ZX, You P, Liu PG, Wang F,
Huang CL, Yao XB, Chen ZX and Zhang ZY: Clinical significance and
expression of cyclin kinase subunits 1 and 2 in hepatocellular
carcinoma. Liver Int. 30:119–125. 2010. View Article : Google Scholar
|
|
17
|
Xu XC: Tumor-suppressive activity of
retinoic acid receptor-beta in cancer. Cancer Lett. 253:14–24.
2007. View Article : Google Scholar
|
|
18
|
Wan H, Oridate N, Lotan D, Hong WK and
Lotan R: Overexpression of retinoic acid receptor beta in head and
neck squamous cell carcinoma cells increases their sensitivity to
retinoid-induced suppression of squamous differentiation by
retinoids. Cancer Res. 59:3518–3526. 1999.PubMed/NCBI
|
|
19
|
Itamochi H, Kigawa J and Terakawa N:
Mechanisms of chemoresistance and poor prognosis in ovarian clear
cell carcinoma. Cancer Sci. 99:653–658. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sui X, Kong N, Ye L, Han W, Zhou J, Zhang
Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of
apoptosis and autophagy in response to chemotherapeutic agents.
Cancer Lett. 344:174–179. 2014. View Article : Google Scholar
|
|
21
|
Morita SY and Terada T: Molecular
mechanisms for biliary phospholipid and drug efflux mediated by
ABCB4 and bile salts. Biomed Res Int. 2014:9547812014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
DeClerck K and Elble RC: The role of
hypoxia and acidosis in promoting metastasis and resistance to
chemotherapy. Front Biosci (Landmark Ed). 15:213–225. 2010.
View Article : Google Scholar
|
|
23
|
Moldoveanu T, Follis AV, Kriwacki RW and
Green DR: Many players in BCL-2 family affairs. Trends Biochem Sci.
39:101–111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Snigdha S, Smith ED, Prieto GA and Cotman
CW: Caspase-3 activation as a bifurcation point between plasticity
and cell death. Neurosci Bull. 28:14–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamaguchi M: The anti-apoptotic effect of
regucalcin is mediated through multisignaling pathways. Apoptosis.
18:1145–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
